GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivesto AB (OTCPK:OASMY) » Definitions » Price-to-Free-Cash-Flow

Vivesto AB (Vivesto AB) Price-to-Free-Cash-Flow : N/A (As of Apr. 27, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Vivesto AB Price-to-Free-Cash-Flow?

As of today (2024-04-27), Vivesto AB's share price is $0.02. Vivesto AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.04. Hence, Vivesto AB's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Vivesto AB's Price-to-Free-Cash-Flow or its related term are showing as below:

OASMY's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 21.8
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Vivesto AB's Free Cash Flow per Share for the three months ended in Dec. 2023 was $-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.04.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -37.20% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 18.80% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 21.80% per year.

During the past 13 years, Vivesto AB's highest 3-Year average Free Cash Flow per Share Growth Rate was 60.70% per year. The lowest was -97.30% per year. And the median was 11.20% per year.


Vivesto AB Price-to-Free-Cash-Flow Historical Data

The historical data trend for Vivesto AB's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivesto AB Price-to-Free-Cash-Flow Chart

Vivesto AB Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vivesto AB Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vivesto AB's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Vivesto AB's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivesto AB's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivesto AB's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vivesto AB's Price-to-Free-Cash-Flow falls into.



Vivesto AB Price-to-Free-Cash-Flow Calculation

Vivesto AB's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.02/-0.037
=N/A

Vivesto AB's Share Price of today is $0.02.
Vivesto AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Vivesto AB  (OTCPK:OASMY) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Vivesto AB Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Vivesto AB's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivesto AB (Vivesto AB) Business Description

Traded in Other Exchanges
Address
Gustav III:s Boulevard 46, 5th Floor, Solna, SWE, SE-169 73
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.

Vivesto AB (Vivesto AB) Headlines

From GuruFocus